ARCHIVES

Modality Combo Decreases Prostate Cancer Recurrence

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

Obey Aide Objects To Criticism Over Earmarking New NCI Positions

August 13, 1976

DCE Advisors Approve New Epidemiology RFPs Table Proposed RFA

April 16, 1993

DCT Board Okays 11 Concept Contract Recompetitions

October 26, 1984

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007

The Tivozanib Timeline

May 10, 2013

NCI Advisory Group, Other Cancer Meetings

August 16, 1985